209 related articles for article (PubMed ID: 16537903)
1. Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.
Wang GL; Shi X; Salisbury E; Sun Y; Albrecht JH; Smith RG; Timchenko NA
Mol Cell Biol; 2006 Apr; 26(7):2570-82. PubMed ID: 16537903
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone corrects proliferation and transcription of phosphoenolpyruvate carboxykinase in livers of old mice via elimination of CCAAT/enhancer-binding protein alpha-Brm complex.
Wang GL; Shi X; Salisbury E; Sun Y; Albrecht JH; Smith RG; Timchenko NA
J Biol Chem; 2007 Jan; 282(2):1468-78. PubMed ID: 17107955
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging.
Smith RG; Sun Y; Jiang H; Albarran-Zeckler R; Timchenko N
Ann N Y Acad Sci; 2007 Nov; 1119():147-64. PubMed ID: 18056963
[TBL] [Abstract][Full Text] [Related]
4. HDAC1 cooperates with C/EBPalpha in the inhibition of liver proliferation in old mice.
Wang GL; Salisbury E; Shi X; Timchenko L; Medrano EE; Timchenko NA
J Biol Chem; 2008 Sep; 283(38):26169-78. PubMed ID: 18622015
[TBL] [Abstract][Full Text] [Related]
5. C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4.
Wang H; Iakova P; Wilde M; Welm A; Goode T; Roesler WJ; Timchenko NA
Mol Cell; 2001 Oct; 8(4):817-28. PubMed ID: 11684017
[TBL] [Abstract][Full Text] [Related]
6. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
7. The proline-histidine-rich CDK2/CDK4 interaction region of C/EBPalpha is dispensable for C/EBPalpha-mediated growth regulation in vivo.
Porse BT; Pedersen TA; Hasemann MS; Schuster MB; Kirstetter P; Luedde T; Damgaard I; Kurz E; Schjerling CK; Nerlov C
Mol Cell Biol; 2006 Feb; 26(3):1028-37. PubMed ID: 16428455
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
[TBL] [Abstract][Full Text] [Related]
9. Regulation of apoptotic and growth inhibitory activities of C/EBPalpha in different cell lines.
Wang GL; Shi X; Salisbury E; Timchenko NA
Exp Cell Res; 2008 Apr; 314(7):1626-39. PubMed ID: 18313667
[TBL] [Abstract][Full Text] [Related]
10. Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin.
Bryja V; Pacherník J; Vondráček J; Souček K; Čajánek L; Horvath V; Holubcová Z; Dvořák P; Hampl A
Cell Prolif; 2008 Dec; 41(6):875-893. PubMed ID: 19040567
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
12. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
13. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.
Wang H; Nicolay BN; Chick JM; Gao X; Geng Y; Ren H; Gao H; Yang G; Williams JA; Suski JM; Keibler MA; Sicinska E; Gerdemann U; Haining WN; Roberts TM; Polyak K; Gygi SP; Dyson NJ; Sicinski P
Nature; 2017 Jun; 546(7658):426-430. PubMed ID: 28607489
[TBL] [Abstract][Full Text] [Related]
14. Dephosphorylated C/EBPalpha accelerates cell proliferation through sequestering retinoblastoma protein.
Wang GL; Timchenko NA
Mol Cell Biol; 2005 Feb; 25(4):1325-38. PubMed ID: 15684384
[TBL] [Abstract][Full Text] [Related]
15. Formation of p27-CDK complexes during the human mitotic cell cycle.
Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
[TBL] [Abstract][Full Text] [Related]
16. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
17. In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.
Yin H; Lowery M; Glass J
Prostate; 2009 Jun; 69(9):1001-16. PubMed ID: 19347879
[TBL] [Abstract][Full Text] [Related]
18. Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence.
Lin J; Jinno S; Okayama H
Oncogene; 2001 Apr; 20(16):2000-9. PubMed ID: 11360184
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E.
Gumina MR; Xu C; Chiles TC
Cell Cycle; 2010 Feb; 9(4):820-8. PubMed ID: 20107311
[TBL] [Abstract][Full Text] [Related]
20. A cyclin D-CDK6 dimer helps to reshuffle cyclin-dependent kinase inhibitors (CKI) to overcome TGF-beta-mediated arrest and maintain CDK2 activity.
Nataraj SE; Blain SW
Cell Cycle; 2021 Apr; 20(8):808-818. PubMed ID: 33794722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
